levodopa and nad
levodopa has been researched along with nad in 10 studies
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Lovstad, RA | 1 |
| Birkmayer, JG; Birkmayer, W; Paletta, B; Vrecko, K | 1 |
| Birkmayer, GJ; Birkmayer, W | 1 |
| Debing, I; Ijzerman, AP; Vauquelin, G | 1 |
| Waring, P | 1 |
| Lange, KW; Riederer, P; Youdim, MB | 1 |
| Butler, J; Land, EJ; Prütz, WA | 1 |
| Danielczik, S; Gerstner, A; Häcker, R; Kuhn, W; Mattern, C; Müller, T; Przuntek, H; Winkel, R | 1 |
| Abdin, AA; Hamouda, HE | 1 |
Reviews
1 review(s) available for levodopa and nad
| Article | Year |
|---|---|
Recent advances in pharmacological therapy of Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agents; Droxidopa; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Levodopa; NAD; Neurologic Examination; Parkinson Disease; Receptors, Dopamine | 1993 |
Trials
1 trial(s) available for levodopa and nad
| Article | Year |
|---|---|
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.
Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Dihydropteridine Reductase; Enzyme Activation; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; NAD; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Tyrosine 3-Monooxygenase | 1996 |
Other Studies
8 other study(ies) available for levodopa and nad
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of penicillamine on the conversion of dopa to dopachrome in the presence of tyrosinase or ceruloplasmin.
Topics: Catechol Oxidase; Ceruloplasmin; Electrons; Free Radicals; In Vitro Techniques; Indolequinones; Indoles; Levodopa; Melanins; NAD; Oxidation-Reduction; Oxygen Consumption; Penicillamine; Quinones | 1976 |
The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients.
Topics: Aged; Disability Evaluation; Humans; Infusions, Intravenous; Levodopa; Middle Aged; NAD; Neurologic Examination; Parkinson Disease | 1990 |
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Humans; Levodopa; Male; Middle Aged; NAD; NADP; Parkinson Disease | 1989 |
Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
Topics: Animals; Cattle; Chloroquine; Chlorpromazine; Electron Transport; Kinetics; Levodopa; Melanins; Melanocytes; NAD; Oxidation-Reduction; Pirenzepine | 1988 |
The time-dependent inactivation of human brain dihydropteridine reductase by the oxidation products of L-dopa.
Topics: Adrenochrome; Brain; Dihydropteridine Reductase; Disulfides; Electrophoresis, Polyacrylamide Gel; Humans; Hydrogen Peroxide; Indolequinones; Indoles; Levodopa; NAD; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Peroxidases; Quinones; Time Factors | 1986 |
Photocatalytic and free radical interactions of the heterocyclic N-oxide resazurin with NADH, GSH, and Dopa.
Topics: Catalysis; Dose-Response Relationship, Radiation; Free Radicals; Gamma Rays; Glutathione; Hydroxyl Radical; Indicators and Reagents; Kinetics; Levodopa; NAD; Oxazines; Oxidation-Reduction; Photochemistry; Spectrophotometry; Time Factors; Xanthenes | 1996 |
Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Levodopa; Mitochondria; NAD; Neurons; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Rotenone; Spectrophotometry; Ubiquinone; Ultrasonography; Vitamins | 2008 |